Coca-Cola Europacific Partners (CCEP) is an entrenched, high-quality bottler generating roughly $2 billion in annual free cash flow. While it operates with structurally lower margins than franchisors like KO, its local monopoly on distribution and vast scale provide a wide economic moat. It is a predictable compounder actively returning capital through dividends and buybacks. Fair value range: low $91.3, high $140, with mid-point at $116.
Analysé: 2026-05-20·Prochaine mise à jour: 2026-08-20·Methodology v2.4·Data cut-off:·Quality gate: pass·Sources: all material sources passed deterministic freshness/provenance gates·Review: automated·Archetype: Mature compounder
Stable 13.3% operating margins prove successful pass-through of severe cost inflation.
Fair value
$116
Margin of safety
+20.6%
Confidence
88/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$91.86Price
Low $91.30
Mid $115.74
High $140.15
Coca-Cola Europacific Partners (CCEP) is an entrenched, high-quality bottler generating roughly $2 billion in annual free cash flow. While it operates with structurally lower margins than franchisors like KO, its local monopoly on distribution and vast scale provide a wide economic moat. It is a predictable compounder actively returning capital through dividends and buybacks.
Exclusive territorial distribution agreements for
Exclusive territorial distribution agreements for top global beverage brands.
Massive local distribution density creating
Massive local distribution density creating insurmountable scale advantages.
Free cash flow for CCEP (CCEP) is computed as operating cash flow minus capital expenditure. We report both the absolute level and the FCF margin against revenue, with five years of trajectory.
Operating cash flow is the primary signal: when OCF is negative or significantly below net income, the cash-flow subsection flags the divergence and traces the cause to working-capital, deferred-revenue, or earnings-quality effects.
Capital expenditure is reported as a percentage of revenue alongside the absolute number. Heavy investment phases are separated from harvesting phases so reinvestment intent is legible.
The financing activity row tracks dividends paid, share repurchases, and net debt issuance. Together with FCF, it answers whether buybacks and dividends are funded organically or by issuing debt.
FAQ
CCEP — frequently asked questions
Based on our latest analysis, CCEP looks meaningfully undervalued. The current price is $91.9 versus a composite fair-value midpoint of $116 (range $91.3–$140), which implies roughly 26.0% upside to the midpoint.
Our composite fair-value range for CCEP is $91.3–$140, with a midpoint of $116. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for CCEP's archetype.
Our current rating for CCEP is Strong Buy with a confidence score of 88/100. Strong Buy. The asset trades at an excessively pessimistic valuation despite durable local monopolies and highly visible $2B+ annual free cash flow. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for CCEP are: Elasticity Breakpoint; Franchisor Margin Extraction; Capital Intensity Spike. The single biggest risk is Elasticity Breakpoint: Consumers reject sustained price hikes, driving permanent volume declines and private label substitution.
Our current rating for CCEP is Strong Buy, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($91.3–$140) versus the current price of $91.9.
CCEP is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for CCEP.
